Home » Topics » Regulatory » Patents

Patents
RSS

Achillion Pharmaceuticals describes novel complement factor D inhibitors

March 20, 2017

Sunshine Lake Pharma identifies urate transporter 1/xanthine oxidase inhibitors

March 17, 2017

Genentech and Xenon Pharmaceuticals develop Nav1.7 channel blockers

March 17, 2017

Jiangsu Hansoh Pharmaceutical Group, Shanghai Hansoh Biomedical present angiotensin AT2 antagonists

March 17, 2017

Actelion Pharmaceuticals discovers antibacterial annulated pyrrolidin-2-one derivatives

March 17, 2017

Taiho Pharmaceutical presents HER2 inhibitors

March 17, 2017

Incyte Corp discovers TAM kinases inhibitors

March 17, 2017

Auckland Uniservices discloses new IDO and/or TDO inhibitors

March 17, 2017

Bristol-Myers Squibb patents activin receptor-like kinase 5 inhibitors

March 17, 2017

Takeda Pharmaceutical patents histone deacetylase inhibitors

March 15, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...